Control Bionics Statistics
Total Valuation
Control Bionics has a market cap or net worth of AUD 8.84 million. The enterprise value is 8.32 million.
Market Cap | 8.84M |
Enterprise Value | 8.32M |
Important Dates
The last earnings date was Monday, May 26, 2025.
Earnings Date | May 26, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Control Bionics has 294.61 million shares outstanding. The number of shares has increased by 126.86% in one year.
Current Share Class | 294.61M |
Shares Outstanding | 294.61M |
Shares Change (YoY) | +126.86% |
Shares Change (QoQ) | +9.11% |
Owned by Insiders (%) | 19.65% |
Owned by Institutions (%) | 5.81% |
Float | 114.48M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.67 |
PB Ratio | 1.37 |
P/TBV Ratio | 3.56 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.20 |
EV / Sales | 1.57 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -1.49 |
Financial Position
The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.07.
Current Ratio | 1.61 |
Quick Ratio | 1.27 |
Debt / Equity | 0.07 |
Debt / EBITDA | n/a |
Debt / FCF | -0.08 |
Interest Coverage | -68.83 |
Financial Efficiency
Return on equity (ROE) is -98.08% and return on invested capital (ROIC) is -58.85%.
Return on Equity (ROE) | -98.08% |
Return on Assets (ROA) | -48.68% |
Return on Invested Capital (ROIC) | -58.85% |
Return on Capital Employed (ROCE) | -102.88% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.59 |
Inventory Turnover | 3.15 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -30.23% in the last 52 weeks. The beta is 0.07, so Control Bionics's price volatility has been lower than the market average.
Beta (5Y) | 0.07 |
52-Week Price Change | -30.23% |
50-Day Moving Average | 0.04 |
200-Day Moving Average | 0.06 |
Relative Strength Index (RSI) | 29.56 |
Average Volume (20 Days) | 101,730 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Control Bionics had revenue of AUD 5.28 million and -6.95 million in losses. Loss per share was -0.03.
Revenue | 5.28M |
Gross Profit | 3.56M |
Operating Income | -6.92M |
Pretax Income | -6.95M |
Net Income | -6.95M |
EBITDA | -6.00M |
EBIT | -6.92M |
Loss Per Share | -0.03 |
Balance Sheet
The company has 972,229 in cash and 453,475 in debt, giving a net cash position of 518,754 or 0.00 per share.
Cash & Cash Equivalents | 972,229 |
Total Debt | 453,475 |
Net Cash | 518,754 |
Net Cash Per Share | 0.00 |
Equity (Book Value) | 6.46M |
Book Value Per Share | 0.03 |
Working Capital | 1.28M |
Cash Flow
In the last 12 months, operating cash flow was -5.58 million and capital expenditures -13,263, giving a free cash flow of -5.59 million.
Operating Cash Flow | -5.58M |
Capital Expenditures | -13,263 |
Free Cash Flow | -5.59M |
FCF Per Share | -0.02 |
Margins
Gross margin is 67.39%, with operating and profit margins of -130.97% and -131.48%.
Gross Margin | 67.39% |
Operating Margin | -130.97% |
Pretax Margin | -131.48% |
Profit Margin | -131.48% |
EBITDA Margin | -113.56% |
EBIT Margin | -130.97% |
FCF Margin | n/a |
Dividends & Yields
Control Bionics does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -126.86% |
Shareholder Yield | n/a |
Earnings Yield | -78.59% |
FCF Yield | -63.24% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Control Bionics has an Altman Z-Score of -3.91. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -3.91 |
Piotroski F-Score | n/a |